Published 2005
| Version v1
Publication
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
Additional details
- URL
- http://hdl.handle.net/11567/299949
- URN
- urn:oai:iris.unige.it:11567/299949
- Origin repository
- UNIGE